Typical deceptive basher post...
rbtree Friday,
Typical deceptive basher post...
rbtree Friday, 08/28/15 11:17:03 PM
Re: A deleted message
Post # of 27462
Not really. There is no change to the halt code, nor will there be. Clearly, CRGP orchestrated a complex fraud meant to deceive everyone, from clearing houses to individual shareholders. As well, it has been deceptive for years, as everything about the company is made up nonsense. As it has been proven there are no mines, and thus, was never any income from operations or sale of same, the financials were blatantly fraudulent.
The scam is toast and will never trade again, imo.
Calissio Resources Group, Inc. (CRGP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Bold African Initiative Alright, folks, let's get into the nitty-gritty of Sinopec's game plan in Africa. There's something to be said about a behemoth like Sinopec rolling out a sustainability report with real substance. We're looking at 33 projects across 16 countries, $5.7 billion in investments. Now, that's not just pocket change. Economic Muscle and Environmental...
Continue Reading
A Wedding Dress Extravaganza in the Desert If you're prowling the bridal aisles looking for that dream dress, Azazie's got a showstopper planned for Phoenix on October 31. This ain't your typical online browsing! Azazie, known for flipping the bridal industry on its noggin, is swooping into Phoenix with a pop-up event that promises to shake up your wedding planning with a...
Continue Reading
Venezuelan Crude Docking in Texas Signals New Energy Dynamics Batten down the hatches, 'cause NABEP's Venezuelan crude has made a splashy arrival in Texas. We're talking 1 million barrels, folks, the first of its kind under a fresh U.S. deal. This ain't your grandpa's oil shipment from the Middle East that takes forever to get here—nope, this crude made a pit stop in...
Continue Reading
Aker Solutions Hits Its Stride in Q3 2026 Alright, let's talk Aker Solutions ASA and their third-quarter results for 2026. This isn't their first rodeo with solid financial performance, and it sure looks like they're keeping the ball rolling this time as well. Word on the street in the Oil & Energy sector is that Aker has managed to stick to their plan and tick off...
Continue Reading
A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...
Continue Reading
Shandong's Bold Move on the Global Stage Imagine the bustling city of Jinan, Shandong's capital, humming with the energy of ambitious enterprises ready to leap into the global arena. That's exactly what unfolded at the conference aimed at forging international ties under the Belt and Road Initiative (BRI). For those out of the loop, this ain't just another business...
Continue Reading
Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...
Continue Reading
Packed Protein, Zero Hassle Every once in a while, something comes along in the food sector that changes the game. Tempo's Protein Max meals might just be it. Launching with a hefty 40 grams of protein in every serving, these meals promise a powerful punch for anyone who's serious about meeting their protein counts without spending hours in the kitchen. Two minutes flat...
Continue Reading
Bracco's Bold Move into U.S. Manufacturing In the bustling world of diagnostic imaging, Bracco's latest announcement is like a welcome jolt. They're shelling out $230 million for a new manufacturing facility in Sanford, North Carolina. If you've been around the block in this sector, this move screams ambition—Bracco's playing the long game here. Strategic Location: A...
Continue Reading
Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...
Continue Reading
Top 5 Most Recently Viewed Articles
Kitron Receives Significant Order from U.S. Army In a major development, Kitron has secured a significant order that promises to enhance its presence in the U.S. defense sector. This order, valued at over USD 5 million annually, presents an exciting opportunity for Kitron to deliver advanced custom electronics tailored for the U.S. Army and allied forces. Production Plans...
Continue Reading
Nvidia's Lead in the Tech Arena Dan Ives, Managing Director at Wedbush Securities, offers a compelling perspective on the current evolution of the technology sector. He suggests that Nvidia Corp. is not just a player but rather a dominant force in the artificial intelligence (AI) revolution. Ives expressed a bold assertion, stating, "At the end of the day, it’s...
Continue Reading
The Crypto-Politics Landscape Ahead of Election As the presidential election approaches, discussions around cryptocurrency are heating up, particularly the role of Bitcoin in politics. Michael Saylor, founder of MicroStrategy, has become a prominent voice in this arena. He sparked a debate among his followers regarding who would best support Bitcoin: former President...
Continue Reading
Groundbreaking Results from Novo Nordisk's Wegovy® Trial The latest findings from Novo Nordisk indicate a significant breakthrough in weight management through the higher dose of Wegovy, which has delivered an impressive average weight loss of 21% for individuals suffering from obesity. The trial results, presented at a prominent diabetes conference, revealed that...
Continue Reading
Recent Insider Trading Activity at Merit Medical Systems On a recent day, it was revealed through an SEC filing that Fred Lampropoulos, the Executive Chairman of Merit Medical Systems (NASDAQ:MMSI), made a noteworthy insider sale. Details of the Insider Sale Lampropoulos decided to sell 5,000 shares of the company, as documented in a Form 4 filing with the U.S. Securities...
Continue Reading